(Q43961067)

28 November 2017

Beta2-agonist tolerance and exercise-induced bronchospasm (English)

1 reference

28 November 2017

1 reference

1

Robert J Hancox

1 reference

28 November 2017

Padmaja Subbarao

2

1 reference

28 November 2017

Dennis Kamada

3

1 reference

28 November 2017

Richard M Watson

4

1 reference

28 November 2017

Fredrick E Hargreave

5

1 reference

28 November 2017

Mark D Inman

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

28 November 2017

1 reference

28 November 2017

165

1 reference

28 November 2017

1068-1070

1 reference

28 November 2017

8

1 reference

Functional antagonism: tolerance produced by inhaled beta 2 agonists

28 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.8.200111-091BC

Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.8.200111-091BC

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.8.200111-091BC

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.8.200111-091BC

Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.165.8.200111-091BC

10.1164/AJRCCM.165.8.200111-091BC

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference